CRISPR Based Technologies and Bio-products


Genome piece of writing and the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will consider the foremost recent developments among the use of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The worldwide marketplace for genetic modification therapies should grow from $2.3 billion in 2018 to achieve $17.4 billion by 2023, growing at a compound annual rate of growth (CAGR) of 49.9% during the forecast period of 2018-2023.


    Related Conference of CRISPR Based Technologies and Bio-products

    August 25-25, 2022

    7th International Conference on Molecular Medicine and Diagnostics

    Singapore City, Singapore
    September 19-20, 2022

    International Summit on Genomics and Proteomics

    Dublin, Ireland
    September 19-20, 2022

    15th World Congress on Stem Cell Research

    Dublin, Ireland
    October 17-18, 2022

    21st International Conference on Structural Biology

    Barcelona, Spain
    November 21-22, 2022

    4th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in